Cytokinetics Inc vs iShares Silver Trust — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while iShares Silver Trust trades at $59.87. The key difference: Cytokinetics Inc is trading nearer its 52-week high, iShares Silver Trust nearer its low. Which is the better fit depends on your goals.
| CYTK | SLV | |
|---|---|---|
Market Cap | $10.63B | — |
Sector | Technology | — |
52-Week High | $87.26 | $105.57 |
52-Week Low | $34.31 | $33.89 |
Enterprise Value | $10.74B | — |
Trailing returns across standard periods
Latest headlines on both assets
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.
Read more on SLV →